Literature DB >> 33443690

The Role of the Transdiaphragmatic Pressure Gradient (TGP) in the Pathophysiology of Proximal Reflux.

Leonardo de Mello Del Grande1, F A M Herbella2, M G Patti3.   

Abstract

INTRODUCTION: An increased transdiaphragmatic pressure gradient (TGP) is a main element for distal gastroesophageal reflux disease (GERD). The role of TGP for proximal reflux is still unclear. This study aims to evaluate the presence, severity, and importance of proximal reflux in relationship to the TGP, comparing healthy volunteers, obese individuals, and patients with chronic obstructive pulmonary disease (COPD).
METHODS: We studied 114 individuals comprising 19 healthy lean volunteers, 47 obese individuals (mean body mass index 45 ± 7 kg/m2), and 48 patients with COPD. All patients underwent high-resolution manometry and dual-channel esophageal pH monitoring. Esophageal motility, thoracic pressure (TP), abdominal pressure (AP), TGP, DeMeester score, and % of proximal acid exposure time (pAET) were recorded.
RESULTS: Pathologic distal GERD was found in 0, 44, and 57% of the volunteers, obese, and COPD groups, respectively. pAET was similar among groups, only higher for obese individuals GERD + as compared to obese individuals GERD - and COPD GERD -. pAET did not correlate with any parameter in healthy individuals, but it correlated with AP in the obese, TP in the COPD individuals, and TGP and DeMeester score in both groups. When all individuals were analyzed as a total, pAET correlated with AP, TGP, and DeMeester score. DeMeester score was the only independent variable that correlated with pAET.
CONCLUSIONS: Our results show that (a) TGP is an important mechanism associated with distal esophageal acid exposure and this fact is linked with proximal acid exposure and (b) obesity and COPD both seem to be primary causes for GERD but not directly for proximal reflux.

Entities:  

Keywords:  Ambulatory dual pH monitoring; Distal gastroesophageal reflux; Esophageal manometry; Gastroesophageal reflux disease; Proximal gastroesophageal reflux; Transdiaphragmatic pressure gradient

Mesh:

Year:  2021        PMID: 33443690     DOI: 10.1007/s11605-020-04849-3

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  6 in total

1.  The prevalence of distal and proximal gastroesophageal reflux in patients awaiting lung transplantation.

Authors:  Matthew P Sweet; Fernando A M Herbella; Lorriana Leard; Charles Hoopes; Jeffrey Golden; Steven Hays; Marco G Patti
Journal:  Ann Surg       Date:  2006-10       Impact factor: 12.969

2.  Gastroesophageal reflux and pulmonary aspiration: incidence, functional abnormality, and results of surgical therapy.

Authors:  C A Pellegrini; T R DeMeester; L F Johnson; D B Skinner
Journal:  Surgery       Date:  1979-07       Impact factor: 3.982

Review 3.  Pathophysiology of Gastroesophageal Reflux Disease.

Authors:  Jan Tack; John E Pandolfino
Journal:  Gastroenterology       Date:  2017-10-14       Impact factor: 22.682

4.  24-h pH-metry and multichannel intraluminal impedance monitoring in obese patients with and without gastroesophageal reflux disease symptoms.

Authors:  Giorgio Ricci; Calogero Amella; Edoardo Forti; Angelo Rossi; Gianluca Bersani; Silvia Dari; Veronica Pasini; Antonella Maimone; Vittorio Alvisi
Journal:  Obes Surg       Date:  2011-01       Impact factor: 4.129

Review 5.  Gastroesophageal reflux disease in the obese: Pathophysiology and treatment.

Authors:  Barbara F Nadaleto; Fernando A M Herbella; Marco G Patti
Journal:  Surgery       Date:  2015-06-06       Impact factor: 3.982

Review 6.  Gastroesophageal Reflux Disease in Obese Patients.

Authors:  Antono C Valezi; Fernando A M Herbella; Francisco Schlottmann; Marco G Patti
Journal:  J Laparoendosc Adv Surg Tech A       Date:  2018-07-13       Impact factor: 1.878

  6 in total
  1 in total

1.  LAPAROSCOPIC ANTIREFLUX SURGERY: ARE OLD QUESTIONS ANSWERED? USEFUL FOR EXTRA-ESOPHAGEAL SYMPTOMS?

Authors:  Marco G Patti; Fernando Augusto Mardiros Herbella
Journal:  Arq Bras Cir Dig       Date:  2022-01-31
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.